Amphastar Pharmaceuticals (AMPH) Earnings (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) earnings from Jun 30, 2013 to Mar 31, 2026. The TTM Amphastar Pharmaceuticals (AMPH) earnings is $79M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Amphastar Pharmaceuticals (AMPH) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -44.06% |
| 3 Years TTM | -5.26% |
| 5 Years TTM | +99.61% |
| 10 Years TTM | +71.50% |
Annual Earnings change of Amphastar Pharmaceuticals (AMPH)
| Year | Earnings | Change |
|---|---|---|
| 2026 | $6.42M | -93.45% |
| 2025 | $98M | -38.51% |
| 2024 | $160M | +15.98% |
| 2023 | $138M | +50.50% |
| 2022 | $91M | +47.12% |
| 2021 | $62M | +4337.14% |
| 2020 | $1.40M | -97.14% |
| 2019 | $49M | -952.61% |
| 2018 | -$5.74M | -257.26% |
| 2017 | $3.65M | -62.83% |
| 2016 | $9.82M | -451.97% |
| 2015 | -$2.79M | -73.93% |
| 2014 | -$11M | -190.22% |
| 2013 | $12M | -34.44% |
| 2012 | $18M | N/A |
Comparison Amphastar Pharmaceuticals (AMPH) five years earnings CAGR with competitors
Amphastar Pharmaceuticals (AMPH) five years earnings CAGR is 99.69%.
| Ticker | Name | five years Earnings CAGR | Upside |
|---|---|---|---|
| INCR | INC Research Holdings Inc | 64.08% | -35.72% |
| TLRY | Tilray Brands Inc | 57.78% | -42.05% |
| PRGO | Perrigo Company plc | 51.08% | -48.76% |
| RGC | Regencell Bioscience Holdings Ltd | 34.56% | -65.33% |
| CPIX | Cumberland Pharmaceuticals Inc | 28.38% | -71.53% |
| UTHR | United Therapeutics Corp | 26.00% | -73.92% |
| SBFM | Sunshine Biopharma Inc | 23.97% | -75.96% |
| RDY | Dr. Reddy`s Laboratories Ltd | 21.66% | -78.27% |
| AYTU | Aytu BioPharma Inc | 21.24% | -78.69% |
| PAHC | Phibro Animal Health Corp - Class A | 17.29% | -82.66% |
| BCRX | Biocryst Pharmaceuticals Inc | 16.93% | -83.02% |
| SNOA | Sonoma Pharmaceuticals Inc | 11.83% | -88.14% |
| NBIX | Neurocrine Biosciences Inc | 10.71% | -89.26% |
| CRDL | Cardiol Therapeutics Inc - Class A | 10.44% | -89.53% |
| ZTS | Zoetis Inc - Class A | 8.54% | -91.44% |
| KMDA | Kamada Ltd | 6.87% | -93.11% |
| AQST | Aquestive Therapeutics Inc | 5.03% | -94.96% |
| PRFX | PRF Technologies Ltd | 4.38% | -95.61% |
| SXTC | China SXT Pharmaceuticals Inc | 3.75% | -96.24% |
| CPHI | China Pharma Holdings Inc | 3.58% | -96.41% |
| BHC | Bausch Health Companies Inc | 3.48% | -96.51% |
| PBH | Prestige Consumer Healthcare Inc | 2.93% | -97.06% |